Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia-Reference-Cited by-同舟云学术

Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia

Published:2019-01 Issue:1 Volume:70 Page:33-39
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Iversen Jenny,Dore Gregory J.,Catlett Beth,Cunningham Philip,Grebely Jason,Maher Lisa

Funder

Australian Government Department of Health

National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Hepatology

Reference36 articles.

1. Hepatitis C virus therapeutic development: in pursuit of “perfectovir”;Dore;Clin Infect Dis,2015

2. Combating hepatitis B and C to reach elimination by 2030;World Health Organization,2016

3. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway;Lancet,2016

4. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

5. Epidemiology and natural history of HCV infection;Hajarizadeh;Nat Rev Gastroenterol Hepatol,2013

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Publisher's Note;International Journal of Drug Policy;2024-09

2. Evaluating the effect of direct-acting antiviral agent treatment scale-up on Hepatitis C virus prevalence among people who inject drugs in UK;International Journal of Drug Policy;2024-06

3. Hepatitis C treatment outcomes among people who inject drugs experiencing unstable versus stable housing: Systematic review and meta-analysis;PLOS ONE;2024-04-26

4. Strategies of hepatitis C virus elimination for people who inject drugs receiving opioid agonist therapy in the era of direct‐acting antivirals;Advances in Digestive Medicine;2024-04-07

5. In search of a ‘good number’: knowledge controversy and population estimates in the endgame of hepatitis C elimination;BMJ Global Health;2024-02